Inactief instrument

Andere talen TherapeuticsMD Inc Nyse

Aandelen

TherapeuticsMD: Q1 Earnings Snapshot	10/05
TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
TherapeuticsMD Announces First Quarter 2024 Financial Results	10/05
TherapeuticsMD Announces Full Year 2023 Financial Results	01/04
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
TherapeuticsMD Announces Full Year 2023 Financial Results	29/03
Knight Therapeutics Announces Launch of Bijuva in Canada	06/02
Knight Therapeutics Announces Product Launch For IMVEXXY In Canada	04/01
North American Morning Briefing : Stocks Seen Building on CPI Rally; PPI Data Due	15/11
TherapeuticsMD: Q3 Earnings Snapshot	15/11
TherapeuticsMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
TherapeuticsMD Announces Third Quarter 2023 Financial Results	14/11
TherapeuticsMD, Inc. Announces Evaluation of Strategic Alternatives	14/11
TherapeuticsMD, Inc. Announces Executive Changes	18-08-23
TherapeuticsMD: Q2 Earnings Snapshot	14-08-23
TherapeuticsMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
TherapeuticsMD Announces Second Quarter 2023 Financial Results	14-08-23
North American Morning Briefing : Stock Futures -2-	14-08-23
TherapeuticsMD : Change in Certifying Accountants - Form 8-K	10-07-23
TherapeuticsMD, Inc.(NasdaqGS:TXMD) added to Russell 3000E Growth Index	23-06-23

Geen resultaten voor deze zoekopdracht